F. Kelestimur Et Al. , "Sheehan's syndrome: baseline characteristics and effect of 2 years of growth hormone replacement therapy in 91 patients in KIMS - Pfizer International Metabolic Database," EUROPEAN JOURNAL OF ENDOCRINOLOGY , vol.152, no.4, pp.581-587, 2005
Kelestimur, F. Et Al. 2005. Sheehan's syndrome: baseline characteristics and effect of 2 years of growth hormone replacement therapy in 91 patients in KIMS - Pfizer International Metabolic Database. EUROPEAN JOURNAL OF ENDOCRINOLOGY , vol.152, no.4 , 581-587.
Kelestimur, F., Jonsson, P., Molvalilar, S., Gomez, J., Auernhammer, C., Colak, R., ... Koltowska-Haggstrom, M.(2005). Sheehan's syndrome: baseline characteristics and effect of 2 years of growth hormone replacement therapy in 91 patients in KIMS - Pfizer International Metabolic Database. EUROPEAN JOURNAL OF ENDOCRINOLOGY , vol.152, no.4, 581-587.
Kelestimur, Hasan Et Al. "Sheehan's syndrome: baseline characteristics and effect of 2 years of growth hormone replacement therapy in 91 patients in KIMS - Pfizer International Metabolic Database," EUROPEAN JOURNAL OF ENDOCRINOLOGY , vol.152, no.4, 581-587, 2005
Kelestimur, Hasan F. Et Al. "Sheehan's syndrome: baseline characteristics and effect of 2 years of growth hormone replacement therapy in 91 patients in KIMS - Pfizer International Metabolic Database." EUROPEAN JOURNAL OF ENDOCRINOLOGY , vol.152, no.4, pp.581-587, 2005
Kelestimur, F. Et Al. (2005) . "Sheehan's syndrome: baseline characteristics and effect of 2 years of growth hormone replacement therapy in 91 patients in KIMS - Pfizer International Metabolic Database." EUROPEAN JOURNAL OF ENDOCRINOLOGY , vol.152, no.4, pp.581-587.
@article{article, author={Hasan Fahrettin KELEŞTEMUR Et Al. }, title={Sheehan's syndrome: baseline characteristics and effect of 2 years of growth hormone replacement therapy in 91 patients in KIMS - Pfizer International Metabolic Database}, journal={EUROPEAN JOURNAL OF ENDOCRINOLOGY}, year=2005, pages={581-587} }